Estimating the relative excess risk due to interaction: A Bayesian approach

Epidemiology

Volumn 22, Issue 2, 2011, Pages 242-248

  Chu, Haitao ^a   Nie, Lei ^b   Cole, Stephen R ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BAYES THEOREM; BODY MASS; BOOTSTRAPPING; CASE CONTROL STUDY; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; EPIDEMIOLOGICAL DATA; HUMAN; MALE; MATHEMATICAL COMPUTING; MOUTH CANCER; PRIORITY JOURNAL; RELATIVE EXCESS RISK DUE TO INTERACTION; RISK ASSESSMENT; RISK FACTOR; SMOKING; VARIANCE;

BAYES THEOREM; BIAS (EPIDEMIOLOGY); CONFIDENCE INTERVALS; EPIDEMIOLOGIC METHODS; LIKELIHOOD FUNCTIONS; RISK;

EID: 79951576877     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e318208750e     Document Type: Article

References (45)

1. Hosmer DW, Lemeshow S. Confidence-interval estimation of interaction. Epidemiology. 1992;3:452-456.
2. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. New York: Lippincott Williams & Wilkins; 1998.
3. Lundberg M, Fredlund P, Hallqvist J, Diderichsen F. A SAS program calculating three measures of interaction with confidence intervals. Epidemiology. 1996;7:655-656.
4. Zou GY. On the estimation of additive interaction by use of the four-by-two table and beyond. Am J Epidemiol. 2008;168:212-224. (Pubitemid 351951593)
5. Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol. 2009;169:756-760.
6. Nie L, Chu H, Li F, Cole SR. Relative excess risk due to interaction: resampling-based confidence intervals. Epidemiology. 2010;21:552-556.
7. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005; 20:575-579. (Pubitemid 41126030)
8. Kuss O, Schmidt-Pokrzywniak A, Stang A. Confidence intervals for the interaction contrast ratio. Epidemiology. 2010;21:273-274.
9. Maldonado G, Greenland S. A comparison of the performance of model-based confidence-intervals when the correct model form is unknown-coverage of asymptotic means. Epidemiology. 1994;5:171-182. (Pubitemid 24073391)
10. Kalilani L, Atashili J. Measuring additive interaction using odds ratios. Epidemiol Perspect Innov. 2006;3:5.
11. Judge GG, Takayama T. Inequality restrictions in regression analysis. J Am Stat Assoc. 1966;61:166-181.
12. Lovell MC, Prescott E. Multiple regression with inequality constraints- pretesting bias, hypothesis testing and efficiency. J Am Stat Assoc. 1970;65:913-925.
13. Davis WW. Bayesian-analysis of linear-model subject to linear inequality constraints. J Am Stat Assoc. 1978;73:573-579.
14. Gelfand AE, Smith AF. Sampling-based approaches to calculating marginal densities. J Am Stat Assoc. 1990;85:398-409.
15. Carlin BP, Louis TA. Bayesian Methods for Data Analysis. 3rd ed. Boca Raton, FL: Chapman & Hall/CRC; 2008.
16. Ashby D. Bayesian statistics in medicine: a 25 year review. Stat Med. 2006;25:3589-3631. (Pubitemid 44613898)
17. Greenland S. Bayesian perspectives for epidemiological research: I. Foundations and basic methods. Int J Epidemiol. 2006;35:765-775. (Pubitemid 43985575)
18. Greenland S. Bayesian perspectives for epidemiological research. II. Regression analysis. Int J Epidemiol. 2007;36:195-202. (Pubitemid 47061597)
19. Chu H, Wang Z, Cole SR, Greenland S. Sensitivity analysis of misclas-sification: a graphical and a Bayesian approach. Ann Epidemiol. 2006; 16:834-841. (Pubitemid 44780982)
20. Gilks WR, Best NG, Tan KK. Adaptive rejection Metropolis sampling within Gibbs sampling. Appl Stat. 1995;44:455-472.
21. Metropolis N, Rosenbluth A, Rosenbluth M, Teller A, Teller E. Equation of state calculations by fast computing machines. J Chem Phys. 1953; 21:1087-1092.
22. Gelfand AE, Smith AF, Lee TM. Bayesian analysis of constrained parameter and truncated data problems using Gibbs sampling. J Am Stat Assoc. 1992;87:523-532.
23. Chu H, Cole SR. The estimation of risk ratios in cohort studies with common outcomes: a Bayesian approach. Epidemiology. 2010;21:855-862.
24. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci. 1992;138:182-195.
25. Brooks SP, Gelman A. Alternative methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7:434-455. (Pubitemid 128635035)
26. Natarajan R, McCulloch CE. Gibbs sampling with diffuse proper priors: a valid approach to data-driven inference? J Comput Graph Stat. 1998;7:267-277.
27. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Anal. 2006;1:515-533.
28. Chu H, Chen S, Louis TA. Random effects models in a meta-analysis of the accuracy of two diagnostic tests without a gold standard. J Am Stat Assoc. 2009;104:512-523.
29. Rothman K, Keller A. Effect of joint exposure to alcohol and tobacco on risk of cancer of mouth and pharynx. J Chronic Dis. 1972;25:711-716.
30. Zou GY, Donner A. Construction of confidence limits about effect measures: a general approach. Stat Med. 2008;27:1693-1702. (Pubitemid 351566091)
31. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7:286-290. (Pubitemid 26120376)
32. Mundt DJ, Kelsey JL, Golden AL, et al. An epidemiologic study of sports and weight lifting as possible risk factors for herniated lumbar and cervical discs. Am J Sports Med. 1993;21:854-860. (Pubitemid 23333208)
33. Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36:1111-1118. (Pubitemid 350018555)
34. Rothman KJ. Synergy and antagonism in cause-effect relationships. Am J Epidemiol. 1974;99:385-388.
35. Rothman KJ. Estimation of synergy or antagonism. Am J Epidemiol. 1976;103:506-511.
36. Koopman JS. Interaction between discrete causes. Am J Epidemiol. 1981;113:716-724. (Pubitemid 11065974)
37. Skrondal A. Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol. 2003;158:251-258. (Pubitemid 36944418)
38. VanderWeele TJ, Robins JM. The identification of synergism in the sufficient-component-cause framework. Epidemiology. 2007;18:329-339. (Pubitemid 46624942)
39. Van der Weele TJ. Sufficient cause interactions and statistical interactions. Epidemiology. 2009;20:6-13.
40. Greenland S. Interactions in epidemiology: relevance, identification, and estimation. Epidemiology. 2009;20:14-17.
41. Deddens JA, Petersen MR. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes." Am J Epidemiol. 2004;159:213-214.
42. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23:1351-1375. (Pubitemid 38594143)
43. Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26:53-77. (Pubitemid 46099417)
44. Davidian M, Giltinan DM. Nonlinear models for repeated measurement data: an overview and update. J Agric Biol Environ Stat. 2003;8:387-419. (Pubitemid 39364406)
45. Chu H, Halloran ME. Estimating vaccine efficacy using auxiliary outcome data and a small validation sample. Stat Med. 2004;23:2697-2711. (Pubitemid 39206464)